Human Telomerase Reverse Transcriptase Expression Correlates with Vascular Endothelial Growth Factor-Promoted Tumor Cell Proliferation in Prostate Cancer

REFERENCES

• Blackburn E. H. Switching and signalling at the telomere. Cell 2001; 106: 661–673
   PubMed Web of Science ®Google Scholar
• Blasco M. A. Telomerase beyond telomeres. Nat Rev Cancer 2002; 2: 627–632
   PubMed Web of Science ®Google Scholar
• Holt S. E., Wright W. E., Shay J. W. Regulation of telomerase activity in immortal cell lines. Mol Cell Biol. 1996; 16: 2932–2939
   PubMed Web of Science ®Google Scholar
• Forsyth N. R., Wright W. E., Shay J. W. Telomerase and differentiation in multicellular organisms: turn it off, turn it on, and turn it off again. Differentiation 2002; 69: 188–197
   PubMed Web of Science ®Google Scholar
• Fujimoto R., Kamata N., Taki M., Yokoyama K., Tomonari M., Nagayama M., et al. Gene expression of telomerase related proteins in human normal oral and ectocervical epithelial cells. Oral Oncology 2003; 39: 445–452
   PubMed Web of Science ®Google Scholar
• Mitchell J. R., Collins K. Human telomerase activation requires two independent interactions between telomerase RNA and telomerase reverse transcriptase. Molecular Cell 2000; 6: 361–371
   PubMed Web of Science ®Google Scholar
• Franco J. R., Wasinwong Y. Expression of human telomerase reverse transcriptase in laryngeal tissues. Otolaryngology–Head Neck Surg 2004; 131: 124–125
   Google Scholar
• Iczkowski K. A., Pantazis C. G., McGregor D. H., Wu Y., Tawfik O. W. Telomerase reverse transcriptase subunit immunoreactivity: a marker for high-grade prostate carcinoma. Cancer 2002; 95: 2487–93
   PubMed Web of Science ®Google Scholar
• Crocitto L. E., Korns D., Kretzner L., Shevchuk T., Blair S. L., Wilson T. G., et al. Prostate cancer molecular markers GSTP1 and hTERT in expressed prostatic secretions as predictors of biopsy results. Urology 2004; 64: 821–825
   PubMed Web of Science ®Google Scholar
• Orlando C., Gelmini S., Selli C., Pazzagli M. Telomerase in urological malignancy. J Urol 2001; 166: 666–673
   PubMed Web of Science ®Google Scholar
• Natarajian S., Chen Z., Wancewicz E. V., Monia B. P., Corey D. R. Telomerase reverse transcriptase (hTERT) mRNA and telomerase RNA (hTR) as targets for downregulation of telomerase activity. Oligonucleotides 2004; 14: 263–273
   PubMedGoogle Scholar
• Byzova T. V., Goldman C. K., Jankau J., Chen J., Cabrera G., Achen M. G., et al. Adenovirus encoding vascular endothelial growth factor-D induces tissue-specific vascular patterns in vivo. Blood 2002; 99: 4434–4442
   PubMed Web of Science ®Google Scholar
• Greb R., Wallweiner D., Kiesel L. Vascular endothelial growth factor A (VEGF–A) MRNA expression levels decrease after menopause in normal breast tissue but not in breast cancer lesions. British J Cancer 1999; 81: 225–231
   PubMed Web of Science ®Google Scholar
• Ruohola J., Valve E., Karkkainen M., Joukov V., Alitalo K., Harkonen P. Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells. Mol Cell Endocrinology 1999; 49: 29–40
   Google Scholar
• Ferrer F. A., Miller L. J., Lindquist R., Kowalczyk P., Laudone V. P., Albertsen P. C., et al. Expression of vascular endothelial growth factor receptors in human prostate cancer. Urology 1999; 54(3)567–572
   PubMed Web of Science ®Google Scholar
• Zaccagnini G., Gaetano C., Della P. L., Nanni S., Grasselli A., Mangoni R., et al. Telomerase mediates vascular endothelial growth factor-dependent responsiveness in a rat model of hind limb ischemia. J Biol Chem 2005; 280: 14790–14798
   PubMed Web of Science ®Google Scholar
• Byzova T. V., Goldman C. K., Jankau J., Chen J., Cabrera G., Achen M. G., et al. Adenovirus encoding vascular endothelial growth factor–D induces tissue-specific vascular patterns in vivo. Blood 2002; 99(12)4434–42
   PubMed Web of Science ®Google Scholar
• Hao X. P., Willis J. E., Pretlow T. G., Rao J. S., MacLennan G. T., Talbot I. C., et al. Loss of fragile histidinc traid expression in colorectal carcinomas and premalignant lesions. Cancer Res 2000; 60: 18–21
   PubMed Web of Science ®Google Scholar
• Botchkina G. I., Kim R. H., Botchkina I. L., Kirshenbaum A., Frischer Z., Adler H. L. Noninvasive detection of prostate cancer by quantitative analysis of telomerase activity. Clin Cancer Res 2005; 11(9)3243–3249
   PubMed Web of Science ®Google Scholar
• Ikeda S., Shibata T., Funakoshi N. Immunohistochemical detection of telomerase (TERT) protein in benign and malignant tumor cells of the breast. Rinsho Byori 2005; 53(6)487–493
   PubMedGoogle Scholar
• Kurz D. J., Hong Y., Trivier E., Huang H. L., Decary S., Guo H. Z., et al. Fibroblast growth factor-2, but not vascular endothelial growth factor, upregulates telomerase activity in human endothelial cells. Arteriosclerosis, Thrombosis, and Vascular Biology 2003; 23: 748
   PubMed Web of Science ®Google Scholar
• Orlando C., Gelmini S. Telomerase in endocrine and endocrine-dependent tumors. J Steroid Biochem Mol Biol 2001; 78: 201–214
   PubMed Web of Science ®Google Scholar
• Li R., Younes M., Wheeler T. M., Scardino P., Ohori M., Frolov A., et al. Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) in human prostate. Prostate 2004; 58: 193–199
   PubMed Web of Science ®Google Scholar
• Kirkpatrick K. L., Newbold R. F., Mokbel K. The mRNA expression of hTERT in human breast carcinomas correlates with VEGF expression. J Carcinog 2004; 3: 1–4
   PubMedGoogle Scholar
• He C. R., Liu X. J., Yan S. R. The telomerase activity during in vitro committed differentiation of rabbit bone marrow mesenchymal stem cells. Basic Med Sci and Clini. 2003; 23: 431–435
   Google Scholar